Clinical Trial Update: Effect of Clonazepam on REM Sleep Behavior Disorder in Patients With Parkinsonism [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial testing clonazepam for REM sleep behavior disorder in patients with Parkinsonism has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinsonism
• Rem Sleep Behavior Disorder

Drugs mentioned

• Clonazepam (Clonazepam)

Snippet

Sponsor: Seoul National University Hospital | Conditions: REM Sleep Behavior Disorder | Phase 2 | Status: COMPLETED